GWW vs XENE · P/E 27, rev $9.76B vs $2.55B cap
WW Grainger Inc (GWW) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. XENE currently screens at market cap $2.55B.
Not investment advice. Open the GWW and XENE stock pages for the full models.
Not investment advice.